Related Experiment Video
Updated: Apr 21, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Recent advancement in understanding colitis-associated tumorigenesis
Daren Low1, Mari Mino-Kenudson, Emiko Mizoguchi
1*Gastrointestinal Unit, Department of Medicine, †Department of Pathology, and ‡Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Patients with inflammatory bowel disease face increased risk of colitis-associated cancer (CAC). CAC development involves complex interactions between immunity, gut microbiota, and epithelial changes during chronic inflammation.
Area of Science:
- Gastroenterology and Oncology
- Immunology and Microbiology
Background:
- Inflammatory bowel disease (IBD) is linked to an elevated risk of colitis-associated cancer (CAC).
- CAC development is a complex process influenced by multiple factors.
Purpose of the Study:
- To review recent advances in understanding colitis-associated cancer (CAC) in inflammatory bowel disease (IBD).
- To explore the multifactorial nature of CAC development, including immune, microbial, and epithelial factors.
Main Methods:
- Review of current scientific literature on CAC and IBD.
- Analysis of molecular alterations and biological processes involved in CAC pathogenesis.
Main Results:
- CAC development is driven by dysregulated host immunity, enteric microbiota, and epithelial restitution.
- Understanding the different forms of CAC and their underlying molecular mechanisms is crucial.
Conclusions:
- Chronic inflammation in IBD significantly increases CAC risk.
- CAC pathogenesis is orchestrated by dynamic, concurrent dysregulations in host-microbiota-epithelial interactions.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

